$RVTY
REVVITY, INC.

2021 Q3 Form 10-Q Financial Statement

#000003179121000009 Filed on August 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $1.228B $811.7M
YoY Change 51.34% 14.82%
Cost Of Revenue $543.3M $364.4M
YoY Change 49.1% -0.08%
Gross Profit $685.2M $447.3M
YoY Change 53.17% 30.7%
Gross Profit Margin 55.78% 55.11%
Selling, General & Admin $281.8M $221.0M
YoY Change 27.5% 8.26%
% of Gross Profit 41.13% 49.41%
Research & Development $65.82M $49.52M
YoY Change 32.92% 9.13%
% of Gross Profit 9.61% 11.07%
Depreciation & Amortization $75.62M $59.20M
YoY Change 27.74% 11.07%
% of Gross Profit 11.04% 13.23%
Operating Expenses $347.6M $270.5M
YoY Change 28.5% 8.42%
Operating Profit $332.5M $175.6M
YoY Change 89.3% 123.29%
Interest Expense $16.75M $11.59M
YoY Change 44.57% -28.26%
% of Operating Profit 5.04% 6.6%
Other Income/Expense, Net -$6.431M -$10.81M
YoY Change -40.52% -29.82%
Pretax Income $326.1M $164.8M
YoY Change 97.82% 160.58%
Income Tax $80.09M $27.61M
% Of Pretax Income 24.56% 16.75%
Net Earnings $245.9M $137.2M
YoY Change 79.3% 134.23%
Net Earnings / Revenue 20.02% 16.9%
Basic Earnings Per Share $2.20 $1.23
Diluted Earnings Per Share $2.19 $1.23
COMMON SHARES
Basic Shares Outstanding 112.0M shares 111.3M shares
Diluted Shares Outstanding 112.4M shares 111.9M shares

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $572.8M $218.5M
YoY Change 162.16% -44.4%
Cash & Equivalents $572.8M $218.5M
Short-Term Investments
Other Short-Term Assets $181.2M $126.4M
YoY Change 43.35% 7.71%
Inventory $513.4M $477.7M
Prepaid Expenses
Receivables $992.6M $708.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.260B $1.531B
YoY Change 47.58% -1.1%
LONG-TERM ASSETS
Property, Plant & Equipment $379.1M $322.8M
YoY Change 17.43% 8.23%
Goodwill $3.844B $3.107B
YoY Change 23.71% 4.01%
Intangibles $1.562B $1.188B
YoY Change 31.39% -0.92%
Long-Term Investments
YoY Change
Other Assets $486.3M $291.6M
YoY Change 66.8% 3.85%
Total Long-Term Assets $6.479B $5.105B
YoY Change 26.91% 3.33%
TOTAL ASSETS
Total Short-Term Assets $2.260B $1.531B
Total Long-Term Assets $6.479B $5.105B
Total Assets $8.739B $6.637B
YoY Change 31.68% 2.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $324.7M $255.1M
YoY Change 27.27% 34.1%
Accrued Expenses $793.4M $550.1M
YoY Change 44.24% 16.5%
Deferred Revenue $230.7M $35.10M
YoY Change 557.26% 33.97%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.669M $346.3M
YoY Change -98.65% -31.64%
Total Short-Term Liabilities $1.123B $1.163B
YoY Change -3.48% -2.09%
LONG-TERM LIABILITIES
Long-Term Debt $2.349B $1.625B
YoY Change 44.52% -7.19%
Other Long-Term Liabilities $839.0M $703.2M
YoY Change 19.31% 1.91%
Total Long-Term Liabilities $3.187B $2.328B
YoY Change 36.91% -4.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.123B $1.163B
Total Long-Term Liabilities $3.187B $2.328B
Total Liabilities $4.500B $3.669B
YoY Change 22.63% -2.99%
SHAREHOLDERS EQUITY
Retained Earnings $4.117B $2.966B
YoY Change 38.81% 7.65%
Common Stock $215.4M $218.2M
YoY Change -1.29% 11.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.240B $2.967B
YoY Change
Total Liabilities & Shareholders Equity $8.739B $6.637B
YoY Change 31.68% 2.28%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $245.9M $137.2M
YoY Change 79.3% 134.23%
Depreciation, Depletion And Amortization $75.62M $59.20M
YoY Change 27.74% 11.07%
Cash From Operating Activities $287.9M $138.5M
YoY Change 107.84% 29.68%
INVESTING ACTIVITIES
Capital Expenditures -$20.37M -$16.60M
YoY Change 22.74% 0.0%
Acquisitions
YoY Change
Other Investing Activities -$269.7M -$6.900M
YoY Change 3808.75% -44.35%
Cash From Investing Activities -$290.0M -$23.60M
YoY Change 1128.72% -18.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -257.7M -95.80M
YoY Change 169.03% -156.32%
NET CHANGE
Cash From Operating Activities 287.9M 138.5M
Cash From Investing Activities -290.0M -23.60M
Cash From Financing Activities -257.7M -95.80M
Net Change In Cash -259.9M 19.10M
YoY Change -1460.47% -92.3%
FREE CASH FLOW
Cash From Operating Activities $287.9M $138.5M
Capital Expenditures -$20.37M -$16.60M
Free Cash Flow $308.2M $155.1M
YoY Change 98.73% 25.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
PERKINELMER, INC
dei Entity Central Index Key
EntityCentralIndexKey
0000031791
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-02
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112025000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112090000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112025000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112090000 shares
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7204000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9603000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4100000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2200000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
500000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.273
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.238
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
961000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
162000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
134.53
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
96000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
53.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
88.54
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1020000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
46200000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
640000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
72.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
36700000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
12073000 USD
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8812000 USD
CY2021Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3691000 USD
CY2020Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2712000 USD
CY2021Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6182000 USD
CY2020Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3266000 USD
CY2021Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2455000 USD
CY2020Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1052000 USD
CY2021Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-190000 USD
CY2020Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-269000 USD
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11847000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9041000 USD
pki Contractwith Customer Liability Increase Decrease
ContractwithCustomerLiabilityIncreaseDecrease
49600000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-07-04
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-5075
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2052042
dei Entity Address Address Line1
EntityAddressAddressLine1
940 Winter Street,
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02451
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
663-6900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-57100000 USD
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
112114149 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228471000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
811718000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2536160000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464114000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
543277000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
364374000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1065820000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
708747000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
281819000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221026000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
533229000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
429595000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65824000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49521000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126040000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
98435000 USD
CY2021Q3 pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-5063000 USD
CY2020Q3 pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-1158000 USD
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-10807000 USD
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-7016000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
332488000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
175639000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
800264000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
220321000 USD
CY2021Q3 pki Interest And Other Expense Net
InterestAndOtherExpenseNet
6431000 USD
CY2020Q3 pki Interest And Other Expense Net
InterestAndOtherExpenseNet
10812000 USD
pki Interest And Other Expense Net
InterestAndOtherExpenseNet
-6275000 USD
pki Interest And Other Expense Net
InterestAndOtherExpenseNet
20805000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
326057000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
164827000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
806539000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
199516000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80089000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27614000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
181228000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28588000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
245968000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
137213000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
625311000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
170928000 USD
CY2021Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
CY2020Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
CY2021Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
38000 USD
CY2020Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
51000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
76000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
101000 USD
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-38000 USD
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-51000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-76000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-101000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
245930000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
137162000 USD
us-gaap Net Income Loss
NetIncomeLoss
625235000 USD
us-gaap Net Income Loss
NetIncomeLoss
170827000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.20
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.23
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.58
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.54
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.19
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.23
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.56
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.53
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.19
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111973000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111329000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111225000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112417000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111869000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112456000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111756000 shares
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
245930000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
137162000 USD
us-gaap Net Income Loss
NetIncomeLoss
625235000 USD
us-gaap Net Income Loss
NetIncomeLoss
170827000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
11724000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
61568000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-60581000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-17025000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
87000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
105000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11735000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
61655000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-60476000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17026000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
257665000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
198817000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
564759000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
153801000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
572810000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402036000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
992602000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1155109000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
513429000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
514567000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
181151000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
167208000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2259992000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2238920000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
379065000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368304000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
208494000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
207236000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1561534000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1365693000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
3844070000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
3447114000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
486306000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
333048000 USD
CY2021Q3 us-gaap Assets
Assets
8739461000 USD
CY2021Q1 us-gaap Assets
Assets
7960315000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4669000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
380948000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
324711000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
327325000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
793443000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
943916000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1122823000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1652189000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2348523000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1609701000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
838974000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
774531000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
189334000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
188402000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
4499654000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
4224823000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
112025000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
112090000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103394000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
148101000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4116825000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3507262000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92437000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31961000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4239807000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3735492000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8739461000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7960315000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3735492000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
379305000 USD
CY2021Q2 pki Other Comprehensive Income Lossafter Reclassifications Netof Tax
OtherComprehensiveIncomeLossafterReclassificationsNetofTax
-72211000 USD
CY2021Q2 us-gaap Dividends
Dividends
7846000 USD
CY2021Q2 pki Stock Issued During Period Value Stock Options Exercised And Related Income Tax Benefit
StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit
4987000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000 USD
CY2021Q2 pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
42779000 USD
CY2021Q2 pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
4450000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
899000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4002305000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
245930000 USD
CY2021Q3 pki Other Comprehensive Income Lossafter Reclassifications Netof Tax
OtherComprehensiveIncomeLossafterReclassificationsNetofTax
11735000 USD
CY2021Q3 us-gaap Dividends
Dividends
7826000 USD
CY2021Q3 pki Stock Issued During Period Value Stock Options Exercised And Related Income Tax Benefit
StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit
9198000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1624000 USD
CY2021Q3 pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
30145000 USD
CY2021Q3 pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
5022000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1964000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4239807000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2813824000 USD
us-gaap Net Income Loss
NetIncomeLoss
33665000 USD
pki Other Comprehensive Income Lossafter Reclassifications Netof Tax
OtherComprehensiveIncomeLossafterReclassificationsNetofTax
-78681000 USD
us-gaap Dividends
Dividends
7779000 USD
pki Stock Issued During Period Value Stock Options Exercised And Related Income Tax Benefit
StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit
1106000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1256000 USD
pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
6342000 USD
pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
3028000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
997000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2759746000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
137162000 USD
CY2020Q3 pki Other Comprehensive Income Lossafter Reclassifications Netof Tax
OtherComprehensiveIncomeLossafterReclassificationsNetofTax
61655000 USD
CY2020Q3 us-gaap Dividends
Dividends
7803000 USD
CY2020Q3 pki Stock Issued During Period Value Stock Options Exercised And Related Income Tax Benefit
StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit
8967000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1305000 USD
CY2020Q3 pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
327000 USD
CY2020Q3 pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
5125000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1633000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2967463000 USD
us-gaap Net Income Loss
NetIncomeLoss
625235000 USD
us-gaap Net Income Loss
NetIncomeLoss
170827000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-76000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-101000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
625311000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
170928000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12361000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12654000 USD
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-10807000 USD
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-7016000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145822000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120047000 USD
pki Loss Gain On Disposition Of Assets Net
LossGainOnDispositionOfAssetsNet
0 USD
pki Gainondispositionofbusinessesandassetsnet
Gainondispositionofbusinessesandassetsnet
-485000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
477000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-11446000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1724000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1642000 USD
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
27931000 USD
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
0 USD
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
5303000 USD
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
1485000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-155270000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4312000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7239000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
126707000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26795000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20907000 USD
pki Accrued Expenses And Other
AccruedExpensesAndOther
-148226000 USD
pki Accrued Expenses And Other
AccruedExpensesAndOther
-2677000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
761362000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
198646000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34675000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37138000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14507000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7393000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1815000 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
131000 USD
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
702697000 USD
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
2990000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-751879000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45575000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
763545000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
290000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
729000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
188000000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
339605000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
799856000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8242000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
5935000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-5037000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-11826000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-6036000 USD
pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
0 USD
pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
-5200000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14185000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10074000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
72924000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6669000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15697000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15572000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
325267000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120366000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10659000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4658000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
324091000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28047000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
402613000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191894000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726704000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219941000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
572810000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218536000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1750000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1405000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
152144000 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726704000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219941000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company’s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended January 3, 2021, filed with the SEC (the “2020 Form 10-K”). The balance sheet amounts at January 3, 2021 in this report were derived from the Company’s audited 2020 consolidated financial statements included in the 2020 Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the three and six months ended July 4, 2021 and July 5, 2020, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. The fiscal year ending January 2, 2022 ("fiscal year 2021") will include 52 weeks, and the fiscal year ended January 3, 2021 ("fiscal year 2020") included 53 weeks. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted and Issued Accounting Pronouncements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2019-12"). ASU 2019-12 eliminates certain exceptions and adds guidance to reduce complexity in accounting for income taxes. Specifically, this guidance: (1) removes the intraperiod tax allocation exception to the incremental approach; (2) removes the ownership changes in investments exception in determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting and applies this provision on a modified retrospective basis through a cumulative-effect adjustment to retained earnings at the beginning of the period of adoption; and (3) removes the exception to using the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. ASU 2019-12 also simplifies accounting principles by making other changes, including requiring an entity to: (1) evaluate whether a step-up in tax basis of goodwill relates to a business combination or a separate transaction; (2) make a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax and to apply this provision retrospectively to all periods presented; and (3) recognize a franchise tax (or similar tax) that is partially based on income as an income-based tax and apply this provision either retrospectively for all periods presented or on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The provisions of this guidance (except as specifically mentioned above) are to be applied prospectively upon their effective date. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2020, and interim p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eriods within those years. In accordance with ASU 2019-12, the Company adopted the guidance beginning on January 4, 2021. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</span></div>
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228471000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
811718000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228471000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
811718000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228471000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
811718000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2536160000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464114000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2536160000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464114000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2536160000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464114000 USD
CY2021Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
51900000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
59500000 USD
pki Unbilled Receivables Transferred To Accounts Receivables
UnbilledReceivablesTransferredToAccountsReceivables
46200000 USD
pki Contractwith Customer Asset Increase Decrease
ContractwithCustomerAssetIncreaseDecrease
38600000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
230700000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
238100000 USD
pki Number Of Years In Measurement Period From Acquisition Date To Change Underlying Assumptions
NumberOfYearsInMeasurementPeriodFromAcquisitionDateToChangeUnderlyingAssumptions
P1Y
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3300000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3200000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
100000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3000000.0 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2900000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
100000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
10600000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
15100000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5200000 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
800000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7100000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
367000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
192000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
778000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-600000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
457000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
16750000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
11586000 USD
us-gaap Interest Expense
InterestExpense
30876000 USD
us-gaap Interest Expense
InterestExpense
25251000 USD
CY2021Q3 pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
8633000 USD
CY2020Q3 pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
0 USD
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
27931000 USD
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
0 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1319000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
582000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8442000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3989000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6431000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10812000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6275000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20805000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4000000.0 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6400000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3500000 USD
CY2021Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-3300000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1500000 USD
CY2020Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-7600000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
199770000 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
205022000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40646000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35160000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
273013000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
274385000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
513429000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
514567000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2373394000 USD
CY2021Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2378063000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5412000 USD
CY2021Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
19459000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1627761000 USD
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2008954000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5765000 USD
CY2021Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12540000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111973000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111329000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111225000 shares
CY2021Q3 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
344000 shares
CY2020Q3 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
470000 shares
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
352000 shares
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
475000 shares
CY2021Q3 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
100000 shares
CY2020Q3 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
70000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
104000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
56000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112417000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111869000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112456000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111756000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
224000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
390000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
193000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
440000 shares
CY2021Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segments
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228471000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
811718000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2536160000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464114000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
332488000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
175639000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
800264000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
220321000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6431000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10812000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6275000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
200900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20805000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
326057000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
164827000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
806539000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
199516000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-91518000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-30937000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
747000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
747000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-172000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-277000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92437000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31961000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1490950000 USD
CY2021Q3 pki Repurchased Common Shares For Activity Pursuantto Equity Incentive Plans
RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans
8622 shares
CY2021Q3 pki Aggregate Costof Repurchased Common Sharesfor Activity Pursuantto Equity Incentive Plans
AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans
1200000 USD
pki Repurchased Common Shares For Activity Pursuantto Equity Incentive Plans
RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans
70413 shares
pki Aggregate Costof Repurchased Common Sharesfor Activity Pursuantto Equity Incentive Plans
AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans
10300000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
7900000 USD
CY2021Q3 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2021-04-29
CY2021Q1 pki Change In Any One Of Input Assumptions For Various Reporting Units
ChangeInAnyOneOfInputAssumptionsForVariousReportingUnits
0.10
CY2021Q1 us-gaap Goodwill
Goodwill
3447114000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-36957000 USD
pki Goodwill Acquisition Earn Outs And Other Adjustments
GoodwillAcquisitionEarnOutsAndOtherAdjustments
433913000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
3844070000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1295109000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1561534000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1365693000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
59600000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113700000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94000000.0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
180100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94000000.0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
116800000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
224200000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
5900000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-5000000.0 USD
CY2021Q3 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
151300000 USD
pki Percentage Of Business Outside Domestic Country
PercentageOfBusinessOutsideDomesticCountry
0.70
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3124000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
22777000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2953000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
35481000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
35481000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
27000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
9930000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
96000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
10309000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
237000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
879000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
477000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-11446000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3334000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13726000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3334000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13726000 USD
CY2021Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
12100000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
12900000 USD
pki Number Of Years Over Which Estimated Environmental Cost Will Be Paid
NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid
10 years

Files In Submission

Name View Source Status
0000031791-21-000009-index-headers.html Edgar Link pending
0000031791-21-000009-index.html Edgar Link pending
0000031791-21-000009.txt Edgar Link pending
0000031791-21-000009-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pki-07042021xex_311.htm Edgar Link pending
pki-07042021xex_312.htm Edgar Link pending
pki-07042021xex_321.htm Edgar Link pending
pki-20210704.htm Edgar Link pending
pki-20210704.xsd Edgar Link pending
pki-20210704_cal.xml Edgar Link unprocessable
pki-20210704_def.xml Edgar Link unprocessable
pki-20210704_htm.xml Edgar Link completed
pki-20210704_lab.xml Edgar Link unprocessable
pki-20210704_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending